Clinical review: New technologies for prevention of intravascular catheter-related infections

[1]  R. Lütticken,et al.  Inhibitor of complement, Compstatin, prevents polymer-mediated Mac-1 up-regulation of human neutrophils independent of biomaterial type tested. , 2003, Journal of biomedical materials research. Part A.

[2]  S. Saint,et al.  Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use. , 2003, American journal of infection control.

[3]  M. Pavesi,et al.  Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection , 2003, Critical care medicine.

[4]  D. Maki,et al.  The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  D. Maki,et al.  The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  I. Raad,et al.  Intravascular catheter-related infections: new horizons and recent advances. , 2002, Archives of internal medicine.

[7]  G. Donelli,et al.  New Polymer-Antibiotic Systems to Inhibit Bacterial Biofilm Formation: A Suitable Approach to Prevent Central Venous Catheter-Associated Infections , 2002, Journal of chemotherapy.

[8]  M. Mythen,et al.  Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter. , 2001, British journal of anaesthesia.

[9]  D. Goldmann,et al.  A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. , 2001, Pediatrics.

[10]  R. D'Agostino,et al.  Prolonged Antimicrobial Activity of a Catheter Containing Chlorhexidine-Silver Sulfadiazine Extends Protection against Catheter Infections In Vivo , 2001, Antimicrobial Agents and Chemotherapy.

[11]  S. Tambe,et al.  In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. , 2001, The Journal of antimicrobial chemotherapy.

[12]  L. Mermel,et al.  New technologies to prevent intravascular catheter-related bloodstream infections. , 2001, Emerging infectious diseases.

[13]  M. Pérez,et al.  Clinical Trial Evaluating a New Hub Device Designed to Prevent Catheter-Related Sepsis , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[14]  A. Wade,et al.  Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children , 2000, Intensive Care Medicine.

[15]  S. Tebbs,et al.  A prospective clinical study to investigate the microbial contamination ofa needleless connector. , 2000, The Journal of hospital infection.

[16]  J. Klein,et al.  Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  E. Greenberg,et al.  Acyl homoserine-lactone quorum-sensing signal generation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Pham,et al.  Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. , 1999, The Journal of infectious diseases.

[19]  T. Lumley,et al.  Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. , 1999, JAMA.

[20]  T. Elliott,et al.  Prevention of central venous catheter-related infection. , 1998, The Journal of hospital infection.

[21]  J. Timsit,et al.  Clinical Investigations in Critical CareCentral Vein Catheter-Related Thrombosis in Intensive Care Patients: Incidence, Risks Factors, and Relationship With Catheter-Related Sepsis , 1998 .

[22]  B. Meyers,et al.  Study of a Needleless Intermittent Intravenous-Access System for Peripheral Infusions: Analysis of Staff, Patient, and Institutional Outcomes , 1998, Infection Control & Hospital Epidemiology.

[23]  J. Costerton,et al.  The involvement of cell-to-cell signals in the development of a bacterial biofilm. , 1998, Science.

[24]  I. Raad,et al.  Intravascular-catheter-related infections , 1998, The Lancet.

[25]  D. Morck,et al.  Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. , 1998, Critical care medicine.

[26]  W. Jarvis,et al.  Increased Bloodstream Infection Rates in Surgical Patients Associated with Variation from Recommended Use and Care Following Implementation of a Needleless Device , 1998, Infection Control & Hospital Epidemiology.

[27]  E. O'Mara,et al.  Use of an Estimation Method to Derive an Appropriate Denominator to Calculate Central Venous Catheter-Associated Bloodstream Infection Rates , 1998, Infection Control & Hospital Epidemiology.

[28]  J. Hamasaki,et al.  Anaphylactic Shock Induced by an Antiseptic-coated Central Nervous Catheter , 1997 .

[29]  W. D’hoore,et al.  Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. , 1997, The Journal of hospital infection.

[30]  Rabih Darouiche,et al.  Central Venous Catheters Coated with Minocycline and Rifampin for the Prevention of Catheter-Related Colonization and Bloodstream Infections , 1997, Annals of Internal Medicine.

[31]  L. Mermel,et al.  Prevention of Central Venous Catheter-Related Bloodstream Infection by Use of an Antiseptic-Impregnated Catheter , 1997, Annals of Internal Medicine.

[32]  A. Buzaid,et al.  Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  D. Vugia,et al.  Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. , 1996, The Journal of pediatrics.

[34]  I. Raad,et al.  In vitro antimicrobial efficacy of silver iontophoretic catheter. , 1996, Biomaterials.

[35]  J. Rello,et al.  A clinical trial on the prevention of catheter-related sepsis using a new hub model. , 1996, Annals of surgery.

[36]  E. Martin,et al.  Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. , 1996, The Journal of antimicrobial chemotherapy.

[37]  G. Bodey,et al.  The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. , 1996, The Journal of infectious diseases.

[38]  B. Rooney,et al.  Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. , 1995 .

[39]  C. Runowicz,et al.  A prospective randomized comparison of an attached silver-impregnated cuff to prevent central venous catheter-associated infection. , 1995, Gynecologic oncology.

[40]  V. Stallings,et al.  A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. , 1995, The Journal of pediatrics.

[41]  L. Bland,et al.  Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. , 1995, JAMA.

[42]  L. Sampath,et al.  Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. , 1995, Critical care medicine.

[43]  M. Gilchrist.  Recommendations for Preventing the Spread of Vancomycin Resistance , 1995, Infection Control & Hospital Epidemiology.

[44]  P. Collignon.  Intravascular catheter associated sepsis: a common problem , 1994 .

[45]  E. Martin,et al.  Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers. , 1994, The Journal of antimicrobial chemotherapy.

[46]  G. Bodey,et al.  The relationship between the thrombotic and infectious complications of central venous catheters. , 1994, JAMA.

[47]  W. K. Liu,et al.  The effects of electric current on bacteria colonising intravenous catheters. , 1993, The Journal of infection.

[48]  M. LaQuaglia,et al.  A Prospective, Randomized Evaluation of the Effect of Silver Impregnated Subcutaneous Cuffs for Preventing Tunneled Chronic Venous Access Catheter Infections in Cancer Patients , 1993, Annals of surgery.

[49]  S. Bonawitz,et al.  Prevention of central venous catheter sepsis: a prospective randomized trial. , 1991, The American surgeon.

[50]  M. Pfaller,et al.  Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. , 1991, JAMA.

[51]  H. Richet,et al.  Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients , 1990, Journal of clinical microbiology.

[52]  K. Henrickson,et al.  Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  K. J. Schwenzer,et al.  Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. , 1989, JAMA.

[54]  M. Ringer,et al.  An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. , 1988, The American journal of medicine.

[55]  I. Raad,et al.  Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  T. Elliott,et al.  A prospective clinical study to investigate the microbial contamination of a needleless connector , 2000 .

[57]  ohn,et al.  A COMPARISON OF TWO ANTIMICROBIAL-IMPREGNATED CENTRAL VENOUS CATHETERS , 2000 .

[58]  D. Cook,et al.  Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. , 1998, Chest.

[59]  A. Gabrielli,et al.  Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. , 1997, Annals of internal medicine.

[60]  D. Fleming,et al.  Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). , 1995, American journal of infection control.

[61]  P. Collignon.  Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. , 1994, The Medical journal of Australia.

[62]  G. Mcentee,et al.  Effect of a betadine connection shield on central venous catheter sepsis. , 1991, Nutrition.